phy(EMG),oramultimodaldevicecombiningaccelerometryandheartrate.Thereportedsensitivityof
thesedevicesis79.4–96%,withafalsealarmrateof0.20–1.92per24hours(0–0.03pernight).Asingle
phase-3studyvalidatedthedetectionofabsenceseizuresusingasingle-channelwearableEEGdevice.
Twophase-4studiesshowedoverall usersatisfaction withwearableseizure detectiondevices, which
helpeddecreaseinjuriesrelatedtotonic-clonicseizures.Overallsatisfaction,perceivedsensitivity,and
improvementinquality-of-lifeweresignificantlyhigherforvalidateddevices.
Conclusions: Amongthevastnumberofstudiespublishedonseizuredetectiondevices,mostarestrongly